TGAN Stock Price, Transphorm Inc Quote, Chart

Market Summary

USD4.85+0.02

Market Closed

0.41%

TGAN Stock Price

View Fullscreen

TGAN RSI Chart

TGAN Valuation

Market Cap

306.8M

Price/Earnings (Trailing)

-9.2

Price/Sales (Trailing)

16.36

Price/Free Cashflow

-12.65

TGAN Price/Sales (Trailing)

TGAN Profitability

Operating Margin

18.73%

Return on Equity

-182.84%

Return on Assets

-102.16%

Free Cashflow Yield

-7.9%

TGAN Fundamentals

TGAN Revenue

Revenue (TTM)

18.8M

Rev. Growth (Yr)

3.94%

Rev. Growth (Qtr)

-6.79%

TGAN Earnings

Earnings (TTM)

-33.4M

Earnings Growth (Yr)

4.39%

Earnings Growth (Qtr)

-40.29%

Breaking Down TGAN Revenue

Last 7 days

1.3%

Last 30 days

-1.0%

Last 90 days

-0.4%

How does TGAN drawdown profile look like?

TGAN Financial Health

Current Ratio

1.69

TGAN Investor Care

Shares Dilution (1Y)

11.50%

Diluted EPS (TTM)

-0.7

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2023	16.5M	17.2M	18.6M	18.8M
2022	24.1M	26.0M	18.4M	18.2M
2021	12.7M	9.6M	19.0M	21.5M
2020	12.5M	18.3M	19.2M	11.4M
2019	4.0M	6.6M	9.3M	11.9M
2018	0	0	0	1.4M

Get all data in R, Python etc through our Historical Stock Data APIs

Tracking the Latest Insider Buys and Sells of Transphorm Inc

Filter Transactions

Datesorted ascending	Name	Buy/Sell	$ Value	Avg. Price	# Shares	Title
Apr 24, 2024	smales kelly	sold	-2,303	4.85	-475	-
Apr 24, 2024	mcfarland katharina g.	sold	-4,074	4.85	-840	-
Apr 20, 2024	mcfarland katharina g.	acquired	-	-	2,400	-
Apr 20, 2024	humphreys michael julian	acquired	-	-	1,409	-
Apr 20, 2024	moreland cynthia j	acquired	-	-	1,043	-
Apr 20, 2024	smales kelly	acquired	-	-	1,356	-
Apr 04, 2024	smales kelly	sold	-3,753	4.9	-766	-
Feb 29, 2024	parikh primit	sold	-28,806	4.801	-6,000	president and ceo
Feb 28, 2024	smales kelly	sold	-19,224	4.811	-3,996	-
Feb 28, 2024	mcfarland katharina g.	sold	-19,224	4.811	-3,996	-

Which funds bought or sold TGAN recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
Apr 25, 2024	Bank of New York Mellon Corp	reduced	-8.33	73,596	389,230	-%
Apr 23, 2024	AMALGAMATED BANK	reduced	-79.67	-9,000	4,000	-%
Apr 19, 2024	Taylor Frigon Capital Management LLC	sold off	-100	-228,125	-	-%
Apr 16, 2024	Stratos Wealth Partners, LTD.	reduced	-60.21	-43,489	50,097	-%
Apr 05, 2024	CWM, LLC	added	1.09	1,000	3,000	-%
Mar 11, 2024	VANGUARD GROUP INC	added	1.06	2,151,220	5,403,160	-%
Feb 28, 2024	AMERICAN INTERNATIONAL GROUP, INC.	added	3.93	22,097	53,272	-%
Feb 15, 2024	Legal & General Group Plc	reduced	-10.96	3,620	11,421	-%
Feb 15, 2024	BARCLAYS PLC	added	634	136,000	148,000	-%
Feb 14, 2024	SOROS FUND MANAGEMENT LLC	sold off	-100	-754,800	-	-%

Are Funds Buying or Selling TGAN?

Are funds buying TGAN calls or puts?

Calls

Puts

No. of funds holding Calls - Puts

Net Call Options

No. of funds that own TGAN

No. of Funds

Unveiling Transphorm Inc's Major ShareHolders

Date Filed	Name of Filer	Percent of Class	No. of Shares	Form Type
Feb 14, 2024	ameriprise financial inc	7.97%	4,943,812	SC 13G/A
Feb 13, 2024	yaskawa electric corp	7.05%	4,420,000	SC 13G/A
Feb 12, 2024	sas capital co., ltd.	9.16%	5,771,500	SC 13G/A
Jan 25, 2024	hirschman orin	1.6%	996,095	SC 13G/A
Jan 11, 2024	kkr phorm investors l.p.	39.7%	24,724,468	SC 13D/A

Recent SEC filings of Transphorm Inc

View All Filings

Date Filed	Form Type	Document
Apr 26, 2024	4	Insider Trading
Apr 26, 2024	4	Insider Trading
Apr 26, 2024	S-3	S-3
Apr 25, 2024	144	Notice of Insider Sale Intent
Apr 24, 2024	144	Notice of Insider Sale Intent
Apr 23, 2024	4	Insider Trading
Apr 23, 2024	4	Insider Trading
Apr 23, 2024	4	Insider Trading
Apr 23, 2024	4	Insider Trading
Apr 10, 2024	8-K	Current Report

Peers (Alternatives to Transphorm Inc)

Name	Mkt Capsorted ascending	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
LARGE-CAP
NVDA	2.2T	60.9B	-2.84%	222.08%	73.67	35.98	125.85%	581.31%
AMD	254.2B	22.7B	-12.38%	79.95%	297.71	11.21	-3.90%	-35.30%
AMAT	169.0B	26.5B	-2.22%	82.11%	23.61	6.38	0.88%	10.98%
INTC	135.7B	55.2B	-27.16%	6.76%	33.38	2.46	-2.09%	242.32%
ADI	100.2B	11.6B	4.49%	13.73%	35.58	8.66	-8.03%	-17.90%
MID-CAP
AMKR	7.5B	6.5B	-6.51%	38.71%	20.91	1.16	-8.30%	-53.02%
CRUS	4.8B	1.8B	-3.65%	4.49%	27.14	2.67	-11.16%	-46.12%
ACLS	3.4B	1.1B	-8.43%	-11.53%	13.64	2.97	22.89%	34.51%
DIOD	3.3B	1.7B	3.25%	-8.57%	14.7	2.01	-16.94%	-31.42%
AMBA	1.8B	226.5M	-16.01%	-29.36%	-10.41	7.79	-32.92%	-159.10%
SMALL-CAP
ACMR	1.6B	557.7M	-5.82%	189.40%	21.02	2.92	43.44%	97.00%
AOSL	627.2M	640.0M	1.56%	-5.66%	-36.58	0.98	-19.44%	-128.49%
AEHR	331.7M	71.9M	-7.95%	-52.54%	21.53	4.61	14.14%	8.17%
ATOM	118.5M	550.0K	-26.20%	-35.79%	-5.99	215.38	43.98%	-13.47%
ASYS	69.4M	116.7M	-8.26%	-42.81%	-3.62	0.59	15.07%	-240.88%

Transphorm Inc News

Latest updates

Transphorm Inc Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)

(In Thousands)

(*) denotes actual numbers (not divided by Thousands)
Income Statement (Quarterly)																					(In Thousands)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1	2018Q4
Revenue	-6.8%	4,670	5,010	5,883	3,192	4,493	3,670	5,156	4,927	4,604	11,303	3,216	2,425	2,013	1,929	6,329	1,100	9,889	994	488	529	-
Cost Of Revenue	19.8%	4,595	3,836	3,795	3,017	7,162	3,232	4,050	3,789	3,935	2,239	2,567	1,788	1,936	2,043	1,248	1,455	2,281	1,625	1,182	1,404	-
Gross Profit	-93.6%	75.00	1,174	2,088	175	-2,669	438	1,106	1,138	669	9,064	649	637	-	-	-	-	-	-	-	-	-
Costs and Expenses	17.3%	8,996	7,672	8,867	8,518	7,229	5,940	6,140	5,596	5,437	5,130	5,253	5,176	6,460	6,349	5,428	6,531	7,284	5,508	5,373	5,688	-
S&GA Expenses	2.2%	1,745	1,708	1,482	1,651	1,447	1,066	1,083	1,047	976	825	687	663	581	547	528	518	511	572	675	851	10.00
R&D Expenses	-6.1%	2,839	3,022	2,869	3,013	2,325	1,830	1,740	1,632	1,609	1,591	1,823	1,780	1,453	1,071	1,594	1,466	1,901	2,041	2,022	2,182	-
Interest Expenses	-	-	-	8.00	180	184	184	182	181	187	220	204	187	191	191	189	189	191	191	189	187	969*
Income Taxes	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income	-40.3%	-10,001	-7,129	-7,447	-8,792	-10,460	-5,995	-5,353	-4,999	-4,164	5,980	-7,052	-6,579	-4,712	-6,740	-2,270	-4,187	2,434	-5,446	-5,901	-6,370	-11.31
Net Income Margin	2.3%	-1.78*	-1.82*	-1.90*	-1.85*	-1.47*	-1.12*	-0.33*	-0.43*	-0.55*	-0.65*	-2.62*	-1.60*	-1.57*	-	-	-	-	-	-	-	-
Free Cashflow	66.9%	-1,553	-4,697	-8,773	-9,212	7,193	-8,203	-5,636	-5,731	-5,579	-3,892	-5,129	-5,097	-1,434	-	-	-	-	-	-	-	-

Balance Sheet

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Balance Sheet																					(In Millions)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1	2018Q4
Assets	-4.7%	33.00	34.00	34.00	44.00	49.00	58.00	64.00	49.00	55.00	14.00	14.00	18.00	22.00	13.00	18.00	23.00	10.00	10.00	10.00	10.00	10.00
Current Assets	-4.4%	21.00	22.00	20.00	31.00	36.00	47.00	56.00	45.00	51.00	10.00	10.00	14.00	18.00	9.00	13.00	19.00	5.00	0.00	0.00	0.00	5.00
Cash Equivalents	29.2%	8.00	6.00	3.00	16.00	23.00	33.00	43.00	34.00	40.00	2.00	2.00	10.00	15.00	4.00	9.00	15.00	3.00	3.00	4.00	3.00	3.00
Inventory	2.3%	10.00	10.00	9.00	8.00	7.00	9.00	7.00	6.00	6.00	5.00	3.00	2.00	2.00	1.00	1.00	1.00	1.00	-	-	-	1.00
Net PPE	-2.3%	8.00	8.00	8.00	8.00	5.00	5.00	2.00	2.00	2.00	2.00	2.00	1.00	1.00	1.00	2.00	2.00	2.00	-	-	-	2.00
Goodwill	5.9%	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	-	-	-	1.00
Liabilities	36.0%	14.00	11.00	11.00	25.00	21.00	22.00	22.00	17.00	19.00	34.00	45.00	43.00	42.00	42.00	41.00	44.00	47.00	43.00	40.00	36.00	32.00
Current Liabilities	48.8%	12.00	8.00	8.00	22.00	18.00	19.00	19.00	5.00	7.00	22.00	16.00	27.00	27.00	26.00	26.00	30.00	21.00	0.00	0.00	0.00	17.00
Shareholder's Equity	-23.0%	18.00	24.00	23.00	20.00	28.00	36.00	42.00	31.00	36.00	-	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-5.5%	-242	-229	-222	-209	-200	-189	-183	-178	-173	-169	-175	-168	-161	-157	-150	-148	-143	-0.14	-0.13	-0.12	-128
Additional Paid-In Capital	2.8%	262	255	247	230	230	228	228	211	211	151	145	144	143	128	128	128	22.00	0.00	0.00	0.00	22.00
Shares Outstanding	2.0%	63.00	62.00	59.00	57.00	57.00	57.00	54.00	53.00	44.00	41.00	41.00	41.00	32.00	-	-	-	-	-	-	-	-
Float	-	-	-	-	-	-	170	-	-	-	92.00	-	-	-	46,627	-	-	-	-	-	-	-

Cashflow (Last 12 Months)

(In Thousands)

(*) denotes actual numbers (not divided by Thousands)
Cashflow (Quarterly)																					(In Thousands)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1	2018Q4
Cashflow From Operations	63.0%	-1,520	-4,107	-8,773	-7,927	8,800	-4,900	-4,913	-5,826	-5,298	-3,829	-4,783	-4,933	-1,422	-3,181	-3,361	-6,151	-490	-1.39	-565	-5,351	-15.90
Share Based Compensation	65.3%	1,509	913	2,003	857	1,123	636	583	758	848	511	497	513	705	584	104	132	131	159	137	139	-
Cashflow From Investing	94.4%	-33.00	-590	-759	-2,054	-2,639	-4,052	-1,401	-666	-965	-1,126	-2,364	-1,132	-2,033	-1,924	-1,901	-1,548	-1,050	-632	-1,030	-189	-
Cashflow From Financing	-62.1%	2,902	7,654	-2,860	2,411	653	30.00	15,740	-409	44,773	5,000	134	956	13,646	14.00	-	19,498	2,000	4,000	2,008	5,000	-
Buy Backs	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	211	-	-	-	-	-

TGAN Income Statement

2023-12-31

Condensed Consolidated Statements of Operations (unaudited) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2023	Dec. 31, 2022
Income Statement [Abstract]
Revenue, net, including related parties (Note 11)	$ 4,670	$ 4,493	$ 15,563	$ 13,319
Cost of goods sold	4,595	7,162	12,226	14,444
Gross profit (loss)	75	(2,669)	3,337	(1,125)
Operating expenses:
Research and development	2,839	2,325	8,730	5,895
Sales and marketing	1,745	1,447	4,935	3,596
General and administrative	4,412	3,457	11,870	9,818
Total operating expenses	8,996	7,229	25,535	19,309
Loss from operations	(8,921)	(9,898)	(22,198)	(20,434)
Interest expense	0	184	8	550
Loss in joint venture	978	799	2,559	2,065
Other expense (income), net	102	(421)	(188)	(1,241)
Loss before tax expense	(10,001)	(10,460)	(24,577)	(21,808)
Tax expense	0	0	0	0
Net loss	(10,001)	(10,460)	(24,577)	(21,808)
Deemed dividend related to warrant modification and issuance of Inducement Warrants (Note 8)	2,721	0	8,333	0
Net loss attributable to common stockholders	(12,722)	(10,460)	(32,910)	(21,808)
Net loss attributable to common stockholders	$ (12,722)	$ (10,460)	$ (32,910)	$ (21,808)
Net loss per share - basic (in usd per share)	$ (0.20)	$ (0.18)	$ (0.54)	$ (0.38)
Net loss per share - diluted (in usd per share)	$ (0.20)	$ (0.18)	$ (0.54)	$ (0.38)
Weighted average common shares outstanding - basic (in shares)	62,183,843	56,739,450	61,458,945	55,926,828
Weighted average common shares outstanding - diluted (in shares)	62,183,843	56,739,450	61,458,945	55,926,828

TGAN Balance Sheet

2023-12-31

Condensed Consolidated Balance Sheets (unaudited) - USD ($) $ in Thousands	Dec. 31, 2023	Mar. 31, 2023
Current assets:
Cash and cash equivalents	$ 7,951	$ 15,527
Restricted cash	0	500
Accounts receivable, net of allowance for doubtful accounts of $263 and $0 at December 31, 2023 and March 31, 2023, respectively, including related parties (Note 11)	1,721	4,396
Inventory	10,005	8,406
Prepaid expenses and other current assets	1,275	1,859
Total current assets	20,952	30,688
Property and equipment, net	7,679	7,890
Operating lease right-of-use assets	2,311	3,033
Goodwill	1,020	1,079
Intangible assets, net	99	321
Investment in joint venture	0	715
Other assets	601	726
Total assets	32,662	44,452
Current liabilities:
Accounts payable and accrued expenses, including related parties (Note 11)	9,306	7,895
Deferred revenue	10	0
Accrued interest	0	180
Unfunded commitment in joint venture	1,296	0
Accrued payroll and benefits	1,430	1,458
Operating lease liabilities	368	404
Revolving credit facility	0	12,000
Total current liabilities	12,410	21,937
Operating lease liabilities, net of current portion	2,002	2,670
Other liabilities	0	230
Total liabilities	14,412	24,837
Commitments and contingencies (Note 7)
Stockholders’ equity:
Preferred stock, $0.0001 par value; 5,000,000 shares authorized and none issued and outstanding as of December 31, 2023 and March 31, 2023	0	0
Common stock, $0.0001 par value; 750,000,000 shares authorized as of December 31, 2023 and March 31, 2023, and 63,195,948 and 57,047,013 shares issued and outstanding as of December 31, 2023 and March 31, 2023, respectively	6	6
Additional paid-in capital	262,319	230,272
Accumulated deficit	(242,146)	(209,236)
Accumulated other comprehensive loss	(1,929)	(1,427)
Total stockholders’ equity	18,250	19,615
Total liabilities and stockholders’ equity	$ 32,662	$ 44,452

About Transphorm Inc

Transphorm, Inc., a semiconductor company, develops, manufactures, and sells gallium nitride (GaN) semiconductor components for high voltage power conversion applications in Mainland China, Hong Kong, Taiwan, the United States, Japan, South Korea, India, and Europe. The company's products include GaN field effect transistors in various packages. Its GaN devices allows customers to design power systems creating functional value in various end products, including smartphone power adapters/fast-chargers, power supplies for datacenter servers/communication, industrial power converters, chargers/converters/inverters for electric vehicles, and other applications. The company offers its products through regional distributors and sales representatives. Transphorm, Inc. was founded in 2007 and is headquartered in Goleta, California.

CEO	Dr. Primit A. Parikh Ph.D.
WEBSITE	transphormusa.com
INDUSTRY	Semiconductors
EMPLOYEES	131

Transphorm Inc Frequently Asked Questions

What is the ticker symbol for Transphorm Inc? What does TGAN stand for in stocks?

TGAN is the stock ticker symbol of Transphorm Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Transphorm Inc (TGAN)?

As of Fri Apr 26 2024, market cap of Transphorm Inc is 306.84 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of TGAN stock?

You can check TGAN's fair value in chart for subscribers.

What is the fair value of TGAN stock?

You can check TGAN's fair value in chart for subscribers. The fair value of Transphorm Inc is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Transphorm Inc is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for TGAN so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Transphorm Inc a good stock to buy?

The fair value guage provides a quick view whether TGAN is over valued or under valued. Whether Transphorm Inc is cheap or expensive depends on the assumptions which impact Transphorm Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for TGAN.

What is Transphorm Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Fri Apr 26 2024, TGAN's PE ratio (Price to Earnings) is -9.2 and Price to Sales (PS) ratio is 16.36. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. TGAN PE ratio will change depending on the future growth rate expectations of investors.